95 related articles for article (PubMed ID: 15245777)
41. Novel targets in gastric and esophageal cancer.
Valverde CM; Macarulla T; Casado E; Ramos FJ; Martinelli E; Tabernero J
Crit Rev Oncol Hematol; 2006 Aug; 59(2):128-38. PubMed ID: 16829119
[TBL] [Abstract][Full Text] [Related]
42. Molecular and biologic basis of upper gastrointestinal malignancy. Gastric carcinoma.
el-Rifai W; Powell SM
Surg Oncol Clin N Am; 2002 Apr; 11(2):273-91, viii. PubMed ID: 12424850
[TBL] [Abstract][Full Text] [Related]
43. Heat shock protein 90 (HSP90) inhibitors in gastrointestinal cancer: where do we currently stand?-A systematic review.
Magyar CTJ; Vashist YK; Stroka D; Kim-Fuchs C; Berger MD; Banz VM
J Cancer Res Clin Oncol; 2023 Aug; 149(10):8039-8050. PubMed ID: 36966394
[TBL] [Abstract][Full Text] [Related]
44. Combined Ibuprofen-Nanoconjugate Micelles with E-Selectin for Effective Sunitinib Anticancer Therapy.
Zeng X; Teng Y; Zhu C; Li Z; Liu T; Sun Y; Han S
Int J Nanomedicine; 2022; 17():6031-6046. PubMed ID: 36510619
[TBL] [Abstract][Full Text] [Related]
45. Cathepsin S as a target in gastric cancer.
da Costa AC; Santa-Cruz F; Mattos LAR; Rêgo Aquino MA; Martins CR; Bandeira Ferraz ÁA; Figueiredo JL
Mol Clin Oncol; 2020 Feb; 12(2):99-103. PubMed ID: 31929878
[TBL] [Abstract][Full Text] [Related]
46. The effects of BRCA1 expression on the chemosensitivity of gastric cancer cells to platinum agents.
Kim G; Kim J; Han SY; Hwang IG; Kim HS; Min H
Oncol Lett; 2019 Jun; 17(6):5023-5029. PubMed ID: 31186713
[TBL] [Abstract][Full Text] [Related]
47. Microsatellite Instability and Altered Expressions of MLH1 and MSH2 in Gastric Cancer.
Haron NH; Mohamad Hanif EA; Abdul Manaf MR; Yaakub JA; Harun R; Mohamed R; Mohamed Rose I
Asian Pac J Cancer Prev; 2019 Feb; 20(2):509-517. PubMed ID: 30803214
[TBL] [Abstract][Full Text] [Related]
48. Diagnostic and prognostic significance of glypican 5 and glypican 6 gene expression levels in gastric adenocarcinoma.
Dinccelik-Aslan M; Gumus-Akay G; Elhan AH; Unal E; Tukun A
Mol Clin Oncol; 2015 May; 3(3):584-590. PubMed ID: 26137271
[TBL] [Abstract][Full Text] [Related]
49. Aberrant loss of dickkopf-3 in gastric cancer: can it predict lymph node metastasis preoperatively?
Park JM; Kim MK; Chi KC; Kim JH; Lee SH; Lee EJ
World J Surg; 2015 Apr; 39(4):1018-25. PubMed ID: 25604390
[TBL] [Abstract][Full Text] [Related]
50. Identification and characterization of CDH1 germline variants in sporadic gastric cancer patients and in individuals at risk of gastric cancer.
Garziera M; Canzonieri V; Cannizzaro R; Geremia S; Caggiari L; De Zorzi M; Maiero S; Orzes E; Perin T; Zanussi S; De Paoli P; De Re V
PLoS One; 2013; 8(10):e77035. PubMed ID: 24204729
[TBL] [Abstract][Full Text] [Related]
51. Saffron Aqueous Extract Inhibits the Chemically-induced Gastric Cancer Progression in the Wistar Albino Rat.
Bathaie SZ; Miri H; Mohagheghi MA; Mokhtari-Dizaji M; Shahbazfar AA; Hasanzadeh H
Iran J Basic Med Sci; 2013 Jan; 16(1):27-38. PubMed ID: 23638290
[TBL] [Abstract][Full Text] [Related]
52. Upregulated expression of LOX is a novel independent prognostic marker of worse outcome in gastric cancer patients after curative surgery.
Zhang Q; Jin XS; Yang ZY; Wei M; Zhu XC; Wang P; Liu BY; Gu QL
Oncol Lett; 2013 Mar; 5(3):896-902. PubMed ID: 23425977
[TBL] [Abstract][Full Text] [Related]
53. HER-2 Evaluation in a Specific Gastric Cancer Population with the Highest Rate of Mortality in Spain.
Cidon EU; Centeno RG; Lagarto EG; Peral JI
J Oncol; 2011; 2011():391564. PubMed ID: 22131990
[TBL] [Abstract][Full Text] [Related]
54. Cyclooxygenase-2 overexpression in chronic inflammation associated with benign prostatic hyperplasia: is it related to apoptosis and angiogenesis of prostate cancer?
Kim BH; Kim CI; Chang HS; Choe MS; Jung HR; Kim DY; Park CH
Korean J Urol; 2011 Apr; 52(4):253-9. PubMed ID: 21556211
[TBL] [Abstract][Full Text] [Related]
55. Genomic and genetic alterations influence the progression of gastric cancer.
Nobili S; Bruno L; Landini I; Napoli C; Bechi P; Tonelli F; Rubio CA; Mini E; Nesi G
World J Gastroenterol; 2011 Jan; 17(3):290-9. PubMed ID: 21253387
[TBL] [Abstract][Full Text] [Related]
56. Signal transduction proteins in tumors from Puerto Rican and Caucasian gastric adenocarcinoma patients: expression differences with potential for specific targeted therapies.
Cangiano J; Centeno BA; Garrett CR; Cáceres W; de Jesús A; Lee JH; Pavía O; Jove R; Báez L; Sullivan DM; Muro-Cacho CA; Muñoz-Antonia T
Dig Dis Sci; 2008 Aug; 53(8):2090-100. PubMed ID: 18224443
[TBL] [Abstract][Full Text] [Related]
57. SET-CAN, the product of the t(9;9) in acute undifferentiated leukemia, causes expansion of early hematopoietic progenitors and hyperproliferation of stomach mucosa in transgenic mice.
Ozbek U; Kandilci A; van Baal S; Bonten J; Boyd K; Franken P; Fodde R; Grosveld GC
Am J Pathol; 2007 Aug; 171(2):654-66. PubMed ID: 17569777
[TBL] [Abstract][Full Text] [Related]
58. Non-steroidal anti-inflammatory drugs in prevention of gastric cancer.
Dai Y; Wang WH
World J Gastroenterol; 2006 May; 12(18):2884-9. PubMed ID: 16718813
[TBL] [Abstract][Full Text] [Related]
59. Critical interactions between TGF-beta signaling/ELF, and E-cadherin/beta-catenin mediated tumor suppression.
Katuri V; Tang Y; Li C; Jogunoori W; Deng CX; Rashid A; Sidawy AN; Evans S; Reddy EP; Mishra B; Mishra L
Oncogene; 2006 Mar; 25(13):1871-86. PubMed ID: 16288220
[TBL] [Abstract][Full Text] [Related]
60. Prognostic relevance of p53 and bcl-2 immunoreactivity for early invasive pT1/pT2 gastric carcinomas: indicators for limited gastric resections?
Kopp R; Diebold J; Dreier I; Cramer C; Glas J; Baretton G; Jauch KW
Surg Endosc; 2005 Nov; 19(11):1507-12. PubMed ID: 16177872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
